Dupilumab treatment normalizes skin barrier function in children aged 6-11 years with moderate-to-severe atopic dermatitis

被引：0

作者：

Cork, Michael J. ^{[1
]}

Leung, Donald ^{[2
]}

Ong, Peck ^{[3
]}

Danby, Simon ^{[1
]}

Ramirez-Gama, Marco ^{[2
]}

Garcia, Shannon ^{[2
]}

Patricia, Taylor ^{[2
]}

Byers, Rob ^{[1
]}

Matcher, Stephen ^{[1
]}

Zahn, Joseph ^{[4
]}

Bologna, Gabriel ^{[5
]}

Zhang, Annie ^{[6
]}

机构：

[1] Univ Sheffield, Sheffield Dermatol Res, Sheffield, England

[2] Natl Jewish Hlth, Denver, CO USA

[3] Univ Southern Calif, Childrens Hosp Los Angeles, Los Angeles, CA USA

[4] Regeneron Pharmaceut Inc, Tarrytown, NY USA

[5] Ividata Life Sci, Levallois Perret, France

[6] Sanofi, Cambridge, MA USA

来源：

BRITISH JOURNAL OF DERMATOLOGY | 2024年 / 191卷

关键词：

D O I：

10.1093/bjd/ljae090.063

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

P036

引用

页码：I30 / I30

页数：1

共 50 条

[1] Dupilumab treatment normalizes skin barrier function and symptoms in children aged 6-11 years with moderate-to-severe atopic dermatitis
Leung, D. Y.
Cork, M. J.
Ong, P.
Danby, S.
Ramirez-Gama, M.
Garcia, S.
Taylor, P.
Zahn, J.
Bologna, G.
Zhang, A.
ALLERGY, 2023, 78 : 194 - 194
[2] Dupilumab treatment normalizes skin barrier function and improves patient-reported outcomes in patients aged 6 to 11 years with moderate-to-severe atopic dermatitis
Cork, M. J.
Leung, D. Y. M.
Ong, P.
Danby, S. G.
Ramirez-Gama, M.
Garcia, S.
Taylor, P.
Zahn, J.
Praestgaard, A.
Bologna, G.
Zhang, A.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (11) : S342 - S342
[3] Benefits of treatment with dupilumab for children aged 6-11 years with severe atopic dermatitis
不详
BRITISH JOURNAL OF DERMATOLOGY, 2023, 189 (02) : E39 - E39
[4] EFFICACY AND SAFETY OF DUPILUMAB IN CHILDREN AGED 6 MONTHS TO 5 YEARS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
Worrell, Richard
Paller, Amy S.
Siegfried, Elaine C.
Simpson, Eric L.
Wollenberg, Andreas
Gonzalez, Mercedes E.
Sidbury, Robert
Lockshin, Benjamin
Dubost-Brama, Ariane
Bansal, Ashish
INTERNAL MEDICINE JOURNAL, 2022, 52 : 31 - 32
[5] Dupilumab significantly improves skin barrier function in patients with moderate-to-severe atopic dermatitis
Berdyshev, Evgeny
Goleva, Elena
Bissonnette, Robert
Bronova, Irina
Bronoff, Anna Sofia
Richers, Brittany N.
Garcia, Shannon
Ramirez-Gama, Marco
Taylor, Patricia
Praestgaard, Amy
Agueusop, Inoncent
Jurvilliers, Pauline
Boguniewicz, Mark
Levit, Noah A.
Rossi, Ana B.
Zhang, Annie
Leung, Donald Y. M.
ALLERGY, 2022, 77 (11) : 3388 - 3397
[6] DUPILUMAB REDUCES ITCH IN CHILDREN WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS AGED 6 MONTHS TO 5 YEARS
Paller, A. S.
Siegfried, E. C.
Yosipovitch, G.
Kwatra, S. G.
Praestgaard, A.
Prescilla, R.
Wang, J.
VALUE IN HEALTH, 2023, 26 (06) : S57 - S58
[7] Dupilumab Reduces Itch in Children with Moderate-to-Severe Atopic Dermatitis Aged 6 Months to 5 Years
Paller, Amy S.
Siegfried, Elaine C.
Yosipovitch, Gil
Kwatra, Shawn G.
Praestgaard, Amy
Wang, Zhixiao
Prescilla, Randy
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB151 - AB151
[8] Efficacy and safety of dupilumab in children aged ≥ 6 months to < 6 years with moderate-to-severe atopic dermatitis
Paller, Amy S.
Cork, Michael J.
Siegfried, Elaine C.
Simpson, Eric L.
Wollenberg, Andreas
Gonzalez, Mercedes E.
Sun, Yiping
O'Malley, John T.
Bansal, Ashish
BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 : 12 - 12
[9] Dupilumab treatment restores skin barrier function in adult and adolescent patients with moderate-to-severe atopic dermatitis
Goleva, E.
Bissonnette, R.
Berdyshev, E.
Jurvilliers, P.
Agueusop, I.
Praestgaard, A.
Levit, N. A.
Rossi, A.
Zhang, A.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) : S51 - S51
[10] Efficacy and safety of dupilumab in children aged ≥6 months to <6 years with moderate-to-severe atopic dermatitis
Paller, Amy S.
Siegfried, Elaine C.
Simpson, Eric L.
Wollenberg, Andreas
Gonzalez, Mercedes E.
Sidbury, Robert
Lockshin, Benjamin
Xiao, Jing
O'Malley, John T.
Bansal, Ashish
ALLERGY AND ASTHMA PROCEEDINGS, 2022, 43 (06) : 561 - 561

← 1 2 3 4 5 →